Ergoteles LLC Bluebird Bio, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $135,491 - $199,362	23,482 New	23,482 $162,000
Q2 2022 Aug 12, 2022	BUY	$2.94 - $5.23 $909,930 - $1.62 Million	309,500 Added 402.99%	386,300 $1.6 Million
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $225,994 - $588,586	55,527 Added 261.02%	76,800 $372,000
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $190,606 - $346,962	21,273 New	21,273 $213,000
Q2 2021 Aug 12, 2021	SELL	$18.04 - $22.09 $2.32 Million - $2.85 Million	-128,818 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$16.59 - $33.89 $2.14 Million - $4.37 Million	128,818 New	128,818 $3.88 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.